$XENE 3 SEC Filings

Filed On	Filing
17 Oct 2025	Form 3: Kelly Thomas Patrick, Chief Financial Officer Holds 0 shares of No securities are beneficially owned.
24 Jun 2025	Form 3: Cline Darren S, Chief Commercial Officer Holds 0 shares of No securities are beneficially owned.
10 Aug 2023	Form 3: Gover Justin D., Director Holds 0 shares of No securities are beneficially owned.
10 Aug 2023	Form 3: Cannon Gillian, Director Holds 0 shares of No securities are beneficially owned.
09 Nov 2022	Form 3: DiFabio Andrea, Chief Legal Officer Holds 0 shares of No securities are beneficially owned.
25 Aug 2021	Form 3: Kenney Christopher John, Chief Medical Officer Holds 0 shares of No securities are beneficially owned.
03 Jun 2021	Form 3: Garofalo Elizabeth A., Director Holds 0 shares of No securities are beneficially owned.
03 Jun 2021	Form 3: Aulin Sherry, Chief Financial Officer Holds 0 shares of No securities are beneficially owned.
05 Nov 2020	Form 3: Machado Patrick, Director Holds 0 shares of No securities are beneficially owned
17 Aug 2020	Form 3: Von Seggern Christopher, Chief Commercial Officer Holds 0 shares of No securities are beneficially owned.
14 Jan 2020	Form 3: Desjardins Clarissa, Director Holds 0 shares of No securities are beneficially owned
20 Mar 2018	Form 3: Aycardi-fonseca Ernesto, Chief Medical Officer Holds 0 shares of No securities are beneficially owned
27 Sep 2016	Form 3: Svoronos Dawn, Director Holds 0 shares of No securities are beneficially owned
12 Sep 2016	Form 3: Bvf Partners L P/IL, 10% owner and 6 others Holds 1,352,312 shares of Common Stock, no par value per share
04 Apr 2016	Form 3: Winquist Raymond, Head, Translational Research Holds 0 shares of No securities are beneficially owned
09 Feb 2016	Form 3: Empfield James R., SVP, Drug Discovery Holds 0 shares of No securities are beneficially owned
22 May 2015	Form 3: Gannon Steven, Director Holds 0 shares of No securities are beneficially owned
18 Mar 2015	Form 3: Scheller Richard H, Director Holds 0 shares of No securities are beneficially owned
06 Nov 2014	Form 3: Mx Associates, Llp, 10% owner
04 Nov 2014	Form 3: Evans Johnston L, Director

Comments